Literature DB >> 23873328

Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects.

M Rigato1, F Boscari, G Marcuzzo, S Vigili de Kreutzenberg, M C Marescotti, A Avogaro, G P Fadini.   

Abstract

BACKGROUND AND AIMS: Metabolic syndrome (MS) leads to excess cardiovascular disease, including heart failure. Left ventricular hypertrophy (LVH) is common in MS patients, but it is unknown whether onsets of MS and LVH coincide. Herein, we tested the association between development of MS and of electrocardiographic LVH in a cohort of middle-aged individuals.
METHODS: We included 303 working subjects (mean age 43.0 ± 6.2; 41% males), followed- up for 4.3 ± 0.8 yr. ATP-III MS components were determined. Electrocardiographic LVH features were assessed by Sokolow and Cornell voltage indexes and Romhilt-Estes (RE) score.
RESULTS: At baseline, Cornell index was significantly higher in subjects with (no.=55; 18.2%) than in those without MS (12.8 ± 6.4 vs 10.9 ± 5.4 mm; p=0.023), while Sokolow index and RE score were not different. At followup, individuals who developed (no.=51) compared to those who did not develop MS showed a significant increase in Cornell voltage index (1.0 ± 0.6 vs -0.55 ± 0.3 mm; p=0.035) and RE score (0.17 ± 0.17 vs -0.08 ± 0.04; p=0.028). The change in Cornell index over time was directly correlated with the change in the number of MS components (r=0.133; p=0.02) and in homeostasis model assessment of insulin resistance (r=0.117; p=0.046). The association between MS onset and the increase in Cornell index/RE score was independent from confounders.
CONCLUSIONS: In a young population of working subjects, the development of MS is associated with worsening features of LVH. Early LVH electrocardiographic screening in young subjects who develop MS should be considered and performed using Cornell voltage index.

Entities:  

Mesh:

Year:  2013        PMID: 23873328     DOI: 10.3275/9035

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population.

Authors:  Gian Paolo Fadini; Giorgio Marcuzzo; Maria Cristina Marescotti; Saula Vigili de Kreutzenberg; Angelo Avogaro
Journal:  Acta Diabetol       Date:  2012-05-24       Impact factor: 4.280

2.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Authors:  E A Anderson; R P Hoffman; T W Balon; C A Sinkey; A L Mark
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Left ventricular hypertrophy as a predictor of cardiovascular risk.

Authors:  Philippe Gosse
Journal:  J Hypertens Suppl       Date:  2005-04

Review 4.  Electrical remodeling in left ventricular hypertrophy-is there a unifying hypothesis for the variety of electrocardiographic criteria for the diagnosis of left ventricular hypertrophy?

Authors:  Luis Rodriguez-Padial; Ljuba Bacharova
Journal:  J Electrocardiol       Date:  2012-07-17       Impact factor: 1.438

5.  A point-score system for the ECG diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; E H Estes
Journal:  Am Heart J       Date:  1968-06       Impact factor: 4.749

Review 6.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Authors:  Salvatore Mottillo; Kristian B Filion; Jacques Genest; Lawrence Joseph; Louise Pilote; Paul Poirier; Stéphane Rinfret; Ernesto L Schiffrin; Mark J Eisenberg
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

7.  Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up.

Authors:  J Arnlöv; L Lind; B Zethelius; B Andrén; C N Hales; B Vessby; H Lithell
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

8.  The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats.

Authors:  A Holmäng; N Yoshida; E Jennische; A Waldenström; P Björntorp
Journal:  Eur J Clin Invest       Date:  1996-11       Impact factor: 4.686

9.  Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Cecil M Burchfiel; Thomas N Skelton; Michael E Andrew; Robert J Garrison; Donna K Arnett; Daniel W Jones; Herman A Taylor
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

10.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.